Fri, Aug 22, 2014, 4:13 AM EDT - U.S. Markets open in 5 hrs 17 mins


% | $
Quotes you view appear here for quick access.

Zalicus Inc. Message Board

  • zeekingofhill zeekingofhill Sep 28, 2013 9:35 AM Flag

    Hey scistats

    You have been working hard on your ide of top line results by end of next week, but according to the CEO comment from yesterdays PR, he says later this year. Now I take that to mean not next week, but maybe something like November. Lets hope that next week we build a strong base above $1 and avoid RS.

    "The FDA’s designation of Z160 as having orphan drug status is an important milestone for Zalicus as we continue the clinical development work required for potential FDA approval of Z160," commented Mark H.N. Corrigan, MD, President and CEO of Zalicus. “We look forward to evaluating and reporting the activity of Z160 in chronic neuropathic pain indications later this year, including postherpetic neuralgia and lumbosacral radiculopathy.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.180.00(0.00%)Jul 15 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.